Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity.
暂无分享,去创建一个
A. McKenzie | James Cruickshank | Andrew N J McKenzie | Jillian L Barlow | Agustin Bellosi | Clare S Hardman | Lesley F Drynan | See Heng Wong | James P Cruickshank | L. Drynan | S. Wong | J. Barlow | Clare S. Hardman | A. Bellosi
[1] G. McKenzie,et al. A distinct role for interleukin-13 in Th2-cell-mediated immune responses , 1998, Current Biology.
[2] N. Copeland,et al. A highly efficient recombineering-based method for generating conditional knockout mutations. , 2003, Genome research.
[3] D D Donaldson,et al. Interleukin-13: central mediator of allergic asthma , 1998 .
[4] R. Locksley,et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.
[5] Philip Smith,et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. , 2002, Immunity.
[6] K. Chung,et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. , 2007, The Journal of allergy and clinical immunology.
[7] H. Keller. Studies on chemotaxis. 3. Modification of Boyden's technique for the evaluation of chemotactic agents. , 1966, Immunology.
[8] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[9] A. McKenzie,et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.
[10] Dirk E. Smith,et al. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. , 2009, The Journal of allergy and clinical immunology.
[11] Yong‐jun Liu,et al. Interleukin 25 promotes the initiation of proallergic type 2 responses , 2007, The Journal of experimental medicine.
[12] M. Leach,et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.
[13] R. Locksley,et al. Cytokine-secreting follicular T cells shape the antibody repertoire , 2009, Nature Immunology.
[14] Andreas Radbruch,et al. Regulation of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4 gene. , 2001, Immunity.
[15] P. Foster,et al. Mechanism of interleukin‐25 (IL‐17E)‐induced pulmonary inflammation and airways hyper‐reactivity , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] A. McKenzie,et al. Nuocytes and beyond: new insights into helminth expulsion. , 2011, Trends in parasitology.
[17] D. Voehringer,et al. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system , 2006, The Journal of experimental medicine.
[18] K. Rajewsky,et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.
[19] D B Corry,et al. Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.
[20] D. Voehringer,et al. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.
[21] R. Locksley,et al. Requirements for Allergen-Induced Airway Hyperreactivity in T and B Cell-Deficient Mice , 1998, Molecular medicine.
[22] A. McKenzie,et al. Reciprocal expression of IL‐25 and IL‐17A is important for allergic airways hyperreactivity , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[23] Tsutomu Takeuchi,et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.
[24] Ya-Jen Chang,et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.
[25] W. Paul,et al. Basophils Produce IL-4 and Accumulate in Tissues after Infection with a Th2-inducing Parasite , 2004, The Journal of experimental medicine.
[26] R. Homer,et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.
[27] Philip Smith,et al. IL-13 Overexpression Predisposes to Anaphylaxis Following Antigen Sensitization1 , 2001, The Journal of Immunology.
[28] T. Abe,et al. IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.
[29] W. Paul,et al. How are TH2-type immune responses initiated and amplified? , 2010, Nature Reviews Immunology.
[30] Niamh E Mangan,et al. Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.
[31] P. Foster,et al. Integrated Signals Between IL-13, IL-4, and IL-5 Regulate Airways Hyperreactivity , 2000, The Journal of Immunology.
[32] David J. Erle,et al. Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.
[33] D. Umetsu,et al. Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity1 , 2001, The Journal of Immunology.